Procter & Gamble (NYSE:PG) Given New $175.00 Price Target at Raymond James Financial

Key Points

• Raymond James Financial has lowered its price target for Procter & Gamble from $185.00 to $175.00 but maintains an "outperform" rating, suggesting a potential upside of 15.14%.
• Multiple analysts have reduced their price targets for Procter & Gamble, with Barclays setting a new target of $153.00 and Wells Fargo at $170.00, reflecting a generally cautious outlook.
• Procter & Gamble recently reported quarterly earnings of $1.48 per share, exceeding estimates, while revenue grew 1.7% year-over-year to $20.89 billion.

Procter & Gamble (NYSE:PG - Get Free Report) had its price target lowered by investment analysts at Raymond James Financial from $185.00 to $175.00 in a research report issued on Monday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Raymond James Financial's target price would suggest a potential upside of 15.14% from the stock's previous close.

Several other equities analysts have also recently commented on PG. Barclays lowered their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research note on Friday, October 10th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $171.68.

Procter & Gamble Price Performance

Shares of PG traded up $0.59 during mid-day trading on Monday, hitting $151.99. The company's stock had a trading volume of 2,512,594 shares, compared to its average volume of 7,908,051. The firm has a 50-day moving average price of $154.92 and a 200 day moving average price of $158.67. The stock has a market capitalization of $355.72 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 4.02 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble has a fifty-two week low of $146.96 and a fifty-two week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts predict that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Insider Transactions at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 3,986 shares of the company's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares of the company's stock, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the transaction, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Procter & Gamble by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company's stock valued at $37,155,222,000 after purchasing an additional 3,189,111 shares during the period. Kingstone Capital Partners Texas LLC grew its stake in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Procter & Gamble by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company's stock worth $9,439,341,000 after acquiring an additional 1,060,713 shares in the last quarter. Norges Bank bought a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $5,099,644,000. Finally, Northern Trust Corp grew its stake in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after acquiring an additional 248,792 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.